Skip to content

因特格控股

US · ITGR #2239 按市值排名 上市于 1970
126.70 -0.02 -0.02%
实时 - 追踪5344个代码 - 心跳于296秒前 · 2026-10-16 19:30

✦ 量化合理价值 计算方式说明

接近合理价值
82.17 合理价值 ≈ 104.89 127.61
  • 基于该股自身过去5年平均市盈率乘以滚动每股收益,推算出的合理价值区间为82.17-127.61。
  • 当前价格比按平均倍数计算的合理价值(104.89)高20.8%。

估值 各估值倍数与自身5年区间的对比

市净率 2.50 高于历史水平 第76百分位
5年平均 2.11 · 在Medical Devices中排名第63/125
市盈率 34.65 处于历史正常水平 第46百分位
5年平均 36.29 · 前瞻 32.50 · 在Medical Devices中排名第29/38
市销率 2.33 高于历史水平 第70百分位
5年平均 2.07 · 前瞻 2.30 · 在Medical Devices中排名第60/136

同业对比 Medical Devices

公司 市值 市盈率(TTM) 市净率 股息率
因特格控股 (ITGR) 4.31B 34.71 2.51 0.00%
Abbott Laboratories (ABT) 181.50B 33.94 3.55 2.33%
Medtronic (MDT) 121.20B 23.34 2.41 3.01%
Stryker Corp (SYK) 113.02B 30.53 4.71 1.18%
Boston Scientific (BSX) 64.33B 17.97 2.58 0.00%
Edwards Lifesciences (EW) 49.92B 50.35 4.70 0.00%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★★★ 合理价值147.19 经济护城河Narrow 不确定性Medium

当前股价低于晨星合理价值估算16.2%。

合理价值

Integer Holdings Corp earns a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 14% discount to our quantitative fair value estimate of $147.19 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The firm's valuation metrics increase our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its enterprise value to market value ratio of 1.3, which falls in the top 30% compared with peers globally. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. We believe this is a sign that shares could be undervalued.

Conversely, the company's unfavorable dividend structure is potentially concerning. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. The firm's forward dividend yield of 0%, for example, falls in the bottom 30% globally. This could imply a planned dividend cut or relatively high share price, which, despite our favorable price/fair value ratio, is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance bodes well for future returns in light of other contributors to our model.

经济护城河

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

作者:Quantitative Equity Report

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

因特格控股 讨论区 0 条评论

发表评论